GHRP-2 prevented liver inflammatory responses to endotoxin (LPS) in rats, reducing hepatic TNF-α, IL-1β, and NF-κB activation — demonstrating GH secretagogue liver protection through anti-inflammatory mechanisms.
Key findingGHRP-2 administration prevented endotoxin-induced liver inflammation in rats: reduced hepatic TNF-α, IL-1β, IL-6, and NF-κB activation — demonstrating
What the researchers found
GHRP-2 administration prevented endotoxin-induced liver inflammation in rats: reduced hepatic TNF-α, IL-1β, IL-6, and NF-κB activation — demonstrating direct anti-inflammatory hepatoprotection by GH secretagogues independent of GH release.
Why it matters
Relevant for ghrp, inflammation, liver.
How the study worked
animal-study study.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2008.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.
American journal of physiology. Endocrinology and metabolism, 294(1), E131-41
Citation
Granado, Miriam; Martín, Ana Isabel; López-Menduiña, María; López-Calderón, Asunción; Villanúa, M Angeles. (2008). GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia.. American journal of physiology. Endocrinology and metabolism, 294(1), E131-41.